Immunotherapy Combinations in MSI and MSS mCRC

John L. Marshall, MD; Wells A. Messersmith, MD, FACP; Bert H. O’Neil, MD; and Gabriela Chiorean, MD, discuss promising new targets, including immunotherapy combination approaches for patients with microsatellite instability–high and microsatellite stable colorectal cancer tumors.